Pulling SEC filings + quote and writing the call…

Arq, Inc.
Next earnings Aug 10, 2026 · consensus $-0.02 EPS, $28.9M rev
Last earnings -2.5% on 2026-05-06
Growth thesis broke when GAC production paused on design flaws; $6.6M cash vs $20M current debt makes this an un-investable turnaround bet.
Net income -$52.6M · FY2025
Arq is a small-cap activated-carbon maker whose entire bull case rested on ramping its new GAC Facility at Red River to nameplate capacity. That case is now broken on its own terms: after announcing first on-spec commercial volumes in August 2025, management disclosed in December 2025 that ramp-up 'could not be accomplished without further modifications' due to 'design flaws in our GAC Facility,' has 'paused GAC production,' 'idled the Corbin Facility,' and must now switch feedstock from Corbin Wetcake to bituminous coal. In short, the project the company spent heavily to build does not work as designed, the fix is unscoped, and the timeline/cost are unknown — the definition of unknowable risk.
The numbers confirm the stress rather than offset it. FY2025 revenue of $120M (+10.4%) is the only bright spot, but the company posted an operating loss of -$53.0M and a net loss of -$52.6M (operating margin -44.0%), a violent swing that almost certainly embeds impairment/idling charges and dwarfs the modest top-line growth. This is not a one-year blip: net income has been negative every year since FY2022 (-$8.9M, -$12.2M, -$5.1M, then -$52.6M), so the deterioration is accelerating, not stabilizing. Retained earnings collapsed 79% to $13.8M and equity fell 23% to $168M — and that equity is largely the very plant whose recoverability the MD&A flags for impairment testing.
Is ARQ a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $100M | $103M | $99.2M | $109M | $120M |
| Gross profit | — | — | — | — | — |
| Operating income | $4.85M | -$12.1M | -$13.3M | -$1.96M | -$53.0M |
| Net income | $60.4M | -$8.92M | -$12.2M | -$5.11M | -$52.6M |
| Diluted EPS | $3.27 | -$0.48 | -$0.42 | -$0.14 | -$1.27 |
| Net margin | 60.2% | -8.7% | -12.3% | -4.7% | -43.7% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Officer/director change reported (Item 5.02)
Annual meeting vote results plus board/officer change disclosed
Leadership change and other corporate event disclosed
Q1'26: GAC still paused, Corbin idled, cash thin, losses persist
Q1'26: GAC still paused, Corbin idled, cash thin, losses persist
Executive/board change announced (Item 5.02)
DEF 14A proxy for 2026 annual meeting; routine governance items
FY25 net loss $52.6M; GAC design flaws force production pause
Sources: SEC EDGAR (CIK 0001515156, latest 10-Q filed 2026-05-06) · EODHD · Proprietary analysis · as of 6/30/2026, 11:58:55 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 7:58 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 1 sale
| 2026-05-04 | Voncannon Jay Loring Chief Financial Officer | Sell | 16.7K @ $2.27 | $37.9K |
| 2026-03-23 | Wong Joseph M Chief Technology Officer | Tax | 10.1K @ $2.27 | $22.9K |
| 2026-03-23 | Smith Claiborne Benson Gen Counsel, Corp Secretary | Tax | 8.03K @ $2.27 | $18.2K |
| 2026-03-23 | Hansen Stacia Chief Accounting Officer | Tax | 8.89K @ $2.27 | $20.2K |
| 2026-03-23 | Rasmus Robert E. Chief Executive Officer | Tax | 845.00 @ $2.27 | $1.92K |
| 2026-03-23 | Campbell-Breeden Richard Director | Buy | 150K @ $2.21 | $332K |
| 2026-03-17 | Wong Joseph M Chief Technology Officer | Buy | 10.0K @ $1.89 | $18.9K |
| 2026-03-13 | EICHER CAROL S Director | Buy | 77.5K @ $1.95 | $151K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median